SWS Partners Lowers Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

SWS Partners cut its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 33.8% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 2,240 shares of the medical equipment provider’s stock after selling 1,142 shares during the quarter. SWS Partners’ holdings in Intuitive Surgical were worth $1,100,000 as of its most recent SEC filing.

Several other hedge funds have also modified their holdings of ISRG. Creekmur Asset Management LLC increased its holdings in shares of Intuitive Surgical by 200.0% during the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 42 shares in the last quarter. Ridgewood Investments LLC acquired a new position in Intuitive Surgical in the 2nd quarter worth approximately $26,000. Delos Wealth Advisors LLC increased its holdings in Intuitive Surgical by 380.0% in the 1st quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 57 shares during the period. LRI Investments LLC acquired a new position in Intuitive Surgical in the 1st quarter worth approximately $30,000. Finally, LGT Financial Advisors LLC boosted its position in Intuitive Surgical by 415.4% in the 2nd quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock worth $30,000 after purchasing an additional 54 shares in the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Stock Down 2.0 %

NASDAQ:ISRG traded down $9.85 on Tuesday, reaching $477.76. 681,906 shares of the company’s stock were exchanged, compared to its average volume of 1,462,242. The firm has a market capitalization of $169.46 billion, a price-to-earnings ratio of 88.02, a price-to-earnings-growth ratio of 5.40 and a beta of 1.39. The business has a fifty day moving average of $481.33 and a 200-day moving average of $435.81. Intuitive Surgical, Inc. has a 52-week low of $254.85 and a 52-week high of $496.48.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, July 18th. The medical equipment provider reported $1.78 EPS for the quarter, topping analysts’ consensus estimates of $1.54 by $0.24. Intuitive Surgical had a return on equity of 13.04% and a net margin of 27.65%. The business had revenue of $2.01 billion during the quarter, compared to the consensus estimate of $1.97 billion. During the same period in the previous year, the company posted $1.18 earnings per share. The business’s revenue for the quarter was up 14.5% on a year-over-year basis. As a group, equities analysts anticipate that Intuitive Surgical, Inc. will post 5.22 earnings per share for the current year.

Analyst Upgrades and Downgrades

ISRG has been the topic of several recent research reports. Barclays upped their price objective on Intuitive Surgical from $430.00 to $490.00 and gave the stock an “overweight” rating in a research report on Thursday, July 18th. BTIG Research raised their price objective on Intuitive Surgical from $494.00 to $518.00 and gave the company a “buy” rating in a report on Monday. Royal Bank of Canada lifted their price target on Intuitive Surgical from $515.00 to $525.00 and gave the stock an “outperform” rating in a report on Tuesday, October 8th. Morgan Stanley lifted their price target on Intuitive Surgical from $375.00 to $460.00 and gave the stock an “equal weight” rating in a report on Monday, July 15th. Finally, Evercore ISI lifted their price target on Intuitive Surgical from $410.00 to $475.00 and gave the stock an “in-line” rating in a report on Tuesday, October 1st. Six analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. Based on data from MarketBeat, Intuitive Surgical presently has an average rating of “Moderate Buy” and a consensus price target of $467.55.

Insider Transactions at Intuitive Surgical

In other news, Director Craig H. Barratt sold 1,400 shares of the business’s stock in a transaction dated Tuesday, July 23rd. The stock was sold at an average price of $458.13, for a total transaction of $641,382.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In related news, Director Craig H. Barratt sold 1,400 shares of the company’s stock in a transaction that occurred on Tuesday, July 23rd. The stock was sold at an average price of $458.13, for a total value of $641,382.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Mark Brosius sold 2,115 shares of the company’s stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $491.91, for a total value of $1,040,389.65. Following the completion of the transaction, the insider now directly owns 295 shares of the company’s stock, valued at $145,113.45. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 53,120 shares of company stock valued at $25,528,753. 0.90% of the stock is currently owned by corporate insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.